Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cartilage synthesis refers to the biological process by which chondrocytes (specialized cells in cartilage) produce and secrete extracellular matrix components, mainly type II collagen and proteoglycans such as aggrecan, which provide the tissue’s mechanical properties[1][2][3][4][5]. This process is regulated by multiple signaling pathways, growth factors (e.g., FGFs, BMPs, TGF-β), transcription factors (e.g., SOX9), and environmental cues such as mechanical load and hypoxia[1][2][4][5][6]. Disruptions in cartilage synthesis or degradation of this matrix play a central role in diseases such as osteoarthritis and are a major focus of regenerative medicine and tissue engineering approaches[1][2][6]. Key point: “Cartilage synthesis” is a general biologic activity or process, not a molecule, receptor, or protein; it is not a canonical therapeutic target but instead describes the function of targets such as chondrocytes, growth factors, and their receptors.
Activation of chondrocyte differentiation; Upregulation of anabolic gene expression (e.g., SOX9, COL2A1); Modulation of extracellular matrix turnover (balance between synthesis and degradation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage synthesis.